Protection of C57BL/10 mice by vaccination with association of purified proteins from leishmania (leishmania) amazonensis

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 41, Issue 4, 1999, Pages 243-248

  Mora, Ana Maricla ^a   Mayrink, Wilson ^a   Da Costa, Roberto Teodoro ^a   Da Costa, Carlos Alberto ^a   Genaro, Odair ^a   Nascimento, Evaldo ^a  

^a NONE

Author keywords

Leishmania; Mice; Proteins; Vaccine

Indexed keywords

GAMMA INTERFERON; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOAL VACCINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CLINICAL TRIAL; ELECTROPHORESIS; HAMSTER; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEISHMANIA MEXICANA; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; SKIN LEISHMANIASIS; TIME;

ANIMALS; ANTIGENS, PROTOZOAN; CRICETINAE; ELECTROPHORESIS; INTERFERON TYPE II; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TIME FACTORS;

EID: 0033155284     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651999000400008     Document Type: Article

References (42)

1. AFONSO, L.C.C.; SCHARTON, T.M.; VIEIRA, L.Q. & WYSOCKA, M. - The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science, 263: 235-237, 1994.
2. BARRAL-NETO, M.; REED, S.G.; SADIGURSKY, M. & SONNEUFELD, R. - Specific immunization of mice against Leishmania amazonensis using solubilized promastigotes. Clin. exp. Immunol., 139: 11-19, 1987.
3. BARRAL-NETO, M.; BARRAL, A.; BROWNELL, C.E. & SKEIKY, Y.A.W. Transforming growth factor-β in leishmanial infection. Science, 257: 545-548, 1993.
4. BRETSCHER, P.A.; WEI, G.; MENON, B. & BIELEFELDT, H. - Establishment of stable, cell mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science, 257: 539-542, 1992.
5. BURNS, J.M.; SCOTT, J.M.; CARVALHO, E.M. et al. - Characterization of membrane antigen of Leishmania amazonensis that stimulates human immune responses. J. Immunol., 146: 742-748, 1991.
6. BUTTON, L.L. & MCMASTER, W.R. - Molecular cloning of the major surface antigens of Leishmania. J. exp. Med., 167: 724-729, 1988.
7. CÁCERES-DITTMAR, G.; TAPIA, F.J.; SANCHES, M.A. et al. - Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin. exp. Immunol., 91: 500-505, 1993.
8. CAMARGO, E.P. - Growth differentiation in Trypanosoma cancer origin of metacyclic trypanosomes in liquid media. Rev. Inst. Med. trop. 9 Paulo, 6: 93-100, 1964.
9. CARDOSO, S.Y.; MAYRINK,W.;FERNANDES, A.P. et al. - Identification of protective proteins from vaccine against cutaneous leishmaniasis (Leishvacin).Mem. inst. Oswaldo Cruz (submitted in July,1998).
10. CHAMPSI, & McMAHON-PRATT, D. - Membrane glycoprotein M-2 protects against Leshmania amazonensis infection. Infect. Immun., 52: 3272-3279, 1988.
11. CHAN, M.M. - T cell response in murine Leishumtania mexican amazoniasis infection. Production of interferon by CD8+ T cells. Europ. J. Immunol., 23: 1181-1184, 1993.
12. CHATELAIN. R.; VARKILA, K. & COFFMAN. R.L. - ID4 induces a TH2 response in Leish,ania major-infected mice. J. Immunol., 148: 1182-1187,1992.
13. CONVIT, J.; ULRICH, M. & FERNANDEZ, C.T.-The clinical and immunolgical spectrum of American cutaneous leishmaniasis. Trans. roy. Soc. trop. Med. Hyg. 87: 444-448,1993.
14. DA CRUZ, A.; CONCEIÇÃO-SILVA, F.; BERTHO, A.I., & COUTINHO, S.G. Leishmania-reactive CD4+ and CD8+ T cells associated with the cure of human cutaneous leishmaniasis. Infect. Immun., 62: 2614-2618, 1993.
15. FERNANDES, A.P.;HERRERA, E.C.;MAYRINK. W. et al. - Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects. Rev. Inst. Med. trop. S. Paulo, 39: 71-78, 1997.
16. FROMMEL, D.; OGUNKOLADI, B.W.; VOULDOUKIS, I. & MOUNIOUR. I. Vaccine-induced immunity against cutaneous leishmaniasis in Balb/c mice. Infect. Immun., 56: 843-848, 1988.
17. GAZZINELLI, R.T.: BALAS, S.: STEVENS, R. et al. HIV infection sappress type lymptokine and IL-12 responses to Toxoplasma gondii, but fails to inhibit the synthesis of other parisite-induced monokines. J. Immunol., 55: 1565-1574, 1994.
18. HANDMAN, E. & MITCHELL, G.F. - Immunization & the leishmonia receptors for macrophages protects mice against cutaneous leishmaniasis. Proc. nat. Acad. Sci. (Wash.), 82: 5910-5914, 1985.
19. HEINZEL, F.P.; SADICK, M.D.: HOLADAY, B.J.; COFFMAN, R.L. & LOCKSLEY, R.M. - Reciprocal expression of intertferon gamma of interleukin-4 during the resolution or progression of murine leishmaniasis, Evidence for expression of distinct helperT cell subsets. J. exp. Med., 169: 59-72, 1989.
20. LAINSON, R. - The American leishmaniases: some observations on thermocology and epidemiology. Trans, roy. Soc. trop. Mod. Hyg., 77: 569-596, 1983.
21. LIEW, F.Y. - Cell-mediated immunity in experimental cutaneous leishmariasis.Parasit. today, 2: 264-266, 1986.
22. LIEW, E.Y.; HODSON, K. & LELCHUK, J. - Propphylactic immunization against experimental leishmaniasis . VI. Comparison of protective and diseases promoting T cells. J. Immunol., 139: 3112-3117, 1987.
23. LOCKSLEY, R.M. & LOUIS, J.A. - Immunology of leishmaniasis. Corr. Opin. Immunol.,4: 413-416, 1992.
24. LOWRY, O.H.: ROSEMBROUG, N.J.; FARR, L. & RANDALL, R.J. - Protein measurement with the phenol folin reagent. J. biol. Chem., 193: 265-275, 1951.
25. MAYRINK, W.; DA COSTA, C.A.; MAGALHÃES, P.A., et al. - A field of a vaccine against American dermal leishmaniaisis. Trans. roy. Soc. trop. Med. Hyg., 73: 385-387, 1979.
26. McMAHON-PRATT, D.; RODRIGUEZ, D.; RODRIGUEZ, R.J. et al. - Recombinant vaccinia viruses expressing GP46/M2 protect against Leishamenia infection infect. Immun., 61: 3351-3359, 1993.
27. MITCHELL, G.; HANDMAN, E. & SPITHILL, H. - Examination of variable in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major. Int. J. Parasit., 15: 667-684, 1985.
28. MODDABER, F. - Experience with vaccines against leishmaniasis of men and mice. Paraskology, 98: 549-560, 1989.
29. + cells. Int. Immunol., 3. 587-597, 1991.
30. NASCIMENTO, E.; MAYRINK, W.; DA COSTA, C.A. et al. - Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses. Infect. Immun., 58: 2198-2203, 1990.
31. PETERSEN, F. A.; NEVA, F.-A.; OSTER, C.N. & BOGAERT DIAZ, H. - Specific inhibition of lymphocytes proliferation response by adherent suppressor cells in diffuse cutaneous leishmaniasis. New Engl. J. Med., 306: 387-392, 1982.
32. PIRMEZ, C.; YAMAMURA, M.; UEYMURA, K. et al. - Cytokine patterns in the pathogenesis of human leishmaniasis. J. clin. Invest., 91: 1390-1395, 1993.
33. RUSSELL, D. & ALEXANDER, J. - Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol., 140: 1272-1279, 1988.
34. SADICK, M.D.; HENZEL, F.P.; HOLADAY, B.J. et al. - Cure of murine leishmaniasis with anti-interlukin 4 monoclonal antibody. Evidence for a T cell dependent, interferon mechanism, J. exp. Med., 171: 115-127, 1990.
35. SCOTT, P.; PEARCE, E.; NATOVITZ, P. & SHER, A. - Vaccination against cutaneous leishmaniasis in a murine model. II. Immunological properties of protective and non-protective subfractions of a soluble promastigote extract. J. exp. Med., 168: 1675-1684, 1987.
36. SCOTT, P. - The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp. Parasit., 68: 369-372, 1989.
37. -2 modulates the early development of Th1 and Th2 responses in murine model of cutaneous leishmaniasis. J. Immunol., 147: 3149-3155, 1991.
38. SHAV, L.I. & LAINSON, R. - Leishmaniasis in Brasil. X. Some observations on intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. Trans. roy. Soc. trop. Med. Hyg., 69: 323-335, 1975.
39. STENGER, S. THURING, H.; ROLLINGHOFF, M. & BOGDAN, C. - Tissue expression of inducable nitric oxide synthase is closely associated with resistance to Leishmania major. J. exp. Med., 810: 783-793, 1994.
40. SYPEK, J.M.; CHUNG, C.L.; MAYOR, S.E.H. et al. - Resolution of cutaneous leishmaniasis interleukin 12 initates a protective T helper type 1 immune response, J. exp. Med., 177: 1707-1802, 1993.
41. TAPURI, W.L.; TAPURI, W.L.; BARHOSA, A.J.A. et al. - Histopathology and immunocytoclinical study of type 3 and type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev. Inst. Med. trop. S. Paulo, 38: 81-89, 1996.
42. TITUS, R.G.; SHERRY, B. & CERAMI, A. - Tumor necrosis factor plays a protective role in experimental murine leishmaniasis. J. exp. Med., 170: 2079-2104, 1989.